Cannell & Spears’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Cannell & Spears's AMGN Position: Q2 2026 in Review
Cannell & Spears reduced its Amgen (AMGN) stake by 2.4% in Q2 2026, selling an estimated $71.9K and leaving 8,507 shares worth $3.08M. The position accounts for 0.05% of the portfolio, ranked #173.
Cannell & Spears first reported a position in AMGN in Q3 2020 and has held it in 22 quarters since. The position peaked at $4.46M in Q3 2024. 3,149 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Cannell & Spears held 8,507 shares of Amgen worth $3.08M as of Q2 2026.
- Cannell & Spears sold 210 Amgen shares in Q2 2026, an estimated $71.9K.
- Amgen made up 0.05% of Cannell & Spears's portfolio in Q2 2026, its #173 holding.
- Cannell & Spears first reported a position in Amgen in Q3 2020 and has held it in 22 quarters since.
- Cannell & Spears's Amgen position peaked at $4.46M in Q3 2024.
- 3,149 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Cannell & Spears's 13F filing for Q2 2026, filed 11 Aug 2026.